In a groundbreaking move for regional healthcare, LECOM Health Corry Memorial Hospital became the first in the area to offer advanced Positron Emission Tomography (PET) and Computed Tomography (CT) imaging to diagnose dementia, particularly Alzheimer’s disease. In partnership with Vantage Mobile Services, the Hospital has launched a mobile Neuraceq® amyloid PET scan program, enabling doctors to detect amyloid plaque buildup in the brain, a key indicator of Alzheimer’s Disease.
This FDA-approved imaging method provides an essential tool for pinpointing the underlying causes of cognitive decline and guiding treatment with FDA-approved therapies. “Having a clear diagnosis gives patients the opportunity to plan ahead and to access targeted treatments,” commented Dr. Danielle Hansen, Regional President of LECOM Health.
With its low radiation exposure and quick, non-invasive procedure, the Neuraceq scan offers a swift, yet powerful diagnostic solution.
As LECOM Health continues to explore new frontiers in diagnostic care, the Corry Memorial Hospital initiative represents a significant step forward in the fight against Alzheimer’s and other brain diseases.